Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(2 sites)
China
Shenzhen Second People's Hospital, Shenzhen, Guangdong The Ninth People's Hospital of Shanghai Jiao Tong University School of Medicine, Shanghai, Shanghai Municipality